SEMA4D and lung carcinoma: Chen et al. (2019) firstly reported that highly expressed SEMA4D plays an important role in osteolytic bone metastasis of lung cancer by inhibiting osteoblast differentiation, thereby providing a potential strategy for targeting osteoblasts to treat bone metastasis.